PhD in Protein Engineering: 2A Peptides & Ribosome Skipping

ASTRAZENECA UK LIMITED; Cambridge; On-site; GBP 21,000 - 26,000; Full time

Benefits offered by this job

Full funding (maintenance + fees)

Job summary

The University of Cambridge Department of Pathology and the AstraZeneca Discovery Centre in Cambridge invite applications for a 4-year PhD studentship starting 1 October 2027. The project is jointly supervised by Prof.

Andrew Firth and Dr Giovanni Ciotta, spanning both sites to enable cross-institution collaboration on peptide-bond skipping for protein engineering. The project will explore 2A sequences, ribosome skipping, and their biotechnological applications, with opportunities to learn

Qualifications

• First or upper second-class degree from a UK university or equivalent in a relevant subject.
• UK citizens or eligible international students meeting residency requirements.

Responsibilities

• Work on manipulating 2A peptide sequences to aid protein engineering.
• Collaborate across University of Cambridge and AstraZeneca Discovery Centre.

Skills

Biochemistry

Molecular biology

Genetics

Microbiology

Education

Bachelor’s degree in Biochemistry, Microbiology, Cell Biology or Genetics

Job description

The University of Cambridge Department of Pathology and the AstraZeneca Discovery Centre in Cambridge invite applications for a 4-year PhD studentship starting 1 October 2027. The project is jointly supervised by Prof.

Andrew Firth and Dr Giovanni Ciotta, spanning both sites to enable cross-institution collaboration on peptide-bond skipping for protein engineering. The project will explore 2A sequences, ribosome skipping, and their biotechnological applications, with opportunities to learn